August 11, 2026 05:25 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Jharkhand student protest turns tense: Water cannons, lathicharge after Assembly march barricades breached | ‘Mother tongue is as pure as one's mother’: Vijay-led Tamil Nadu government makes Tamil Thaai Vazhthu mandatory in big language push | Indian envoy Kwatra cites US, UK laws to counter ‘myths’ around FCRA Bill | Jharkhand students march to assembly today: JPSC row escalates despite govt action | ‘A morning I will cherish’: Raghav Chadha meets PM Modi, shares photos from ‘enriching’ meeting | Delhi Mercedes crash kills 70-year-old woman: Cop’s son behind wheel, beer bottle found | Indian-origin woman accused of ‘visa fraud’ on X: US Attorney steps in with major clarification | US Senate passes Russia sanctions bill: India can face Trump’s 100% tariff threat | Expired meat, rotten vegetables found at Bengaluru's luxury hotels, legal action begins | 'I'm ready to be humiliated': Vijay, Udhayanidhi Stalin clash in Tamil Nadu Assembly over Cauvery dispute
Covidd-19 Vaccine

Vaccine by the end of 2020 possible, says Union health minister

| @indiablooms | Aug 31, 2020, at 10:47 pm

New Delhi/IBNS: Union health and family welfare minister Dr Harshvardhan said on Monday that a vaccine might be ready in the country by the end of this year, said media report.

The minister said India is not lagging behind anyone else in the world in efforts to contribute towards the development of a coronavirus vaccine.

There are 7-8 vaccine candidates, three of them in the clinical trial phase and the rest in the pre-clinical phase, he informed.

Currently, two vaccine candidates developed in India — Covaxin by Bharat Biotech and ZyCoV-D by Zydus Cadila are in the midst of phase II clinical trial, while Covishield by the University of Oxford has recently started the phase II clinical trial in India.

Vaccine manufacturer AstraZeneca has entered into an agreement with Serum Institute of India to manufacture Oxford's COVID-19 vaccine candidate for India and countries in the low-income group.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.